Discovery of Lead Compounds Targeting Transcriptional Regulation

References

1. Liu B. Zhou H. Tan L. Siu K.T.H. Guan X.Y. Exploring treatment options in cancer: Tumor treatment strategies. Signal. Transduct. Target Ther. 2024 9 1 175 10.1038/s41392‑024‑01856‑7 39013849
   [Google Scholar]
2. Zhong L. Li Y. Xiong L. Wang W. Wu M. Yuan T. Yang W. Tian C. Miao Z. Wang T. Yang S. Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives. Signal. Transduct. Target Ther. 2021 6 1 201 10.1038/s41392‑021‑00572‑w 34054126
   [Google Scholar]
3. Jia G. Jiang Y. Li X. Targeted drug conjugates in cancer therapy: Challenges and opportunities. Pharm. Sci. Adv. 2024 2 100048 10.1016/j.pscia.2024.100048
   [Google Scholar]
4. Bushweller J.H. Targeting transcription factors in cancer — From undruggable to reality. Nat. Rev. Cancer 2019 19 11 611 624 10.1038/s41568‑019‑0196‑7 31511663
   [Google Scholar]
5. Hasan A. Khan N.A. Uddin S. Khan A.Q. Steinhoff M. Deregulated transcription factors in the emerging cancer hallmarks. Semin Cancer Biol. 2024 98 31 50 10.1016/j.semcancer.2023.12.001 38123029
   [Google Scholar]
6. Zhuang J. Liu Q. Wu D. Tie L. Current strategies and progress for targeting the “undruggable” transcription factors. Acta. Pharmacol. Sin 2022 43 10 2474 2481 10.1038/s41401‑021‑00852‑9 35132191
   [Google Scholar]
7. Henley M.J. Koehler A.N. Advances in targeting ‘undruggable’ transcription factors with small molecules. Nat. Rev. Drug Discov. 2021 20 9 669 688 10.1038/s41573‑021‑00199‑0 34006959
   [Google Scholar]
8. Cui H. Stilgenbauer M. Koehler A.N. Small-molecule approaches to target transcription factors. Annu. Rev. Cancer Biol. 2024 8 8 395 415 10.1146/annurev‑cancerbio‑062722‑012209
   [Google Scholar]
9. Wang X. Van P.K.T. Liu B. Zhao T. Wu Y. Targeting the Lin28/let-7 axis with compounds to regulate transcriptional control in cancer. Anticancer Agents Med. Chem. 2025 25 10.2174/0118715206375441250901064006 40968436
   [Google Scholar]
10. Chen H. Guan T. Song J. Chen Y. The function of poly (U) binding splicing factor 60 (PUF60) in disease regulation. Anticancer Agents Med. Chem. 2025 25 10.2174/0118715206346843241119105519 39773058
    [Google Scholar]
11. Hu M. Xu C. Xu M. He S. Liu D. Research progress on small molecule inhibitors of MDM2-p53 protein-protein interaction. Anticancer Agents Med. Chem. 2025 25 10.2174/0118715206358340250121060830 40017256
    [Google Scholar]
12. Zhang C. Yang Y. Gao L.X. Gan S. Li J. Wang X. Zhou Y.B. Wang W.L. Synthesis and evaluation of optical properties, SHP2 inhibitory activity, and cellular imaging for novel 2-quinolone derivatives. Anticancer Agents Med. Chem. 2025 25 10.2174/0118715206337347250219112715 40103459
    [Google Scholar]